Skip to content

LivaNova LIVN Enterprise value

Enterprise value at other companies

Abbott logo
AbbottABT
$205.65B-13.1%
Haemonetics logo
HaemoneticsHAE
$3.65B-12.5%
Medtronic logo
MedtronicMDT
$131.22B-3.2%
ResMed logo
ResMedRMD
$32.14B-2.0%
Boston Scientific logo
Boston ScientificBSX
$141.04B-1.0%
Stryker logo
StrykerSYK
$137.35B-12.4%

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
P/S+0.9×

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Calculated from LivaNova’s reported figures.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's enterprise value?
LivaNova (LIVN) reported enterprise value of $3.28B in Q1 2026.
How has LivaNova's enterprise value changed year-over-year?
LivaNova's enterprise value increased by 58.0% year-over-year, from $2.07B to $3.28B.
What is the long-term trend for LivaNova's enterprise value?
Over 5 years (2020 to 2025), LivaNova's enterprise value has grown at a -3.0% compound annual growth rate (CAGR), from $3.68B to $3.16B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.